跳至主要内容
临床试验/NCT06516042
NCT06516042进行中(未招募)3 期

Effectiveness, Feasibility, and Acceptability of Targeted Antimalarial Interventions for Seasonal Migrant Populations in Metema District, Amhara Region, Ethiopia

PATH1 个研究点 分布在 1 个国家目标入组 10,350 人开始时间: 2024年8月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
10,350
试验地点
1
主要终点
Feasibility of TDA

研究概览

简要总结

The purpose of the study is to assess the effectiveness, feasibility, and acceptability of targeted drug administration for seasonal migrant populations in Metema District, Amhara Region, Ethiopia

详细描述

A cluster randomized controlled trial will be used to evaluate the effectiveness, feasibility, and acceptability of targeted antimalarial drug administration (TDA) for seasonal migrant farmworkers in the Delello farm sites in Metema district, Amhara Region. Individual farm sites will be randomized 1:1:1 to either of two intervention options or control, where all farmworkers at intervention sites will receive either two or three rounds of dihydro artemisinin piperaquine over the primary farming season.

All study farm-sites will receive enhanced case management conducted by mobile health teams throughout the study period.

Cross-sectional surveys will be conducted in all arms at baseline and 4 to 6 weeks following the third round of TDA to assess the effectiveness of the intervention for reducing parasite prevalence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At the time of the study, be a seasonal farm worker at one of the selected farm sites in Metema district
  • Available and willingness to participate in the study and provide consent (or parental/guardian consent and asset in the case of minors)

排除标准

  • Severe illness (will be referred for care)
  • Inability to provide informed consent
  • Age 14-17 years old and not having a parent/guardian at the farm who can provide consent
  • Age <14 years old
  • Additional exclusion criteria for the intervention group:
  • Having received an antimalarial drug within the last 2 weeks
  • Having any of the contraindications to receiving DP:
  • History of cardiac rhythm disturbances, bradycardia, or heart failure
  • Concomitant treatment with drugs that prolong the QT interval (fluconazole, fluoroquinolones, hydroxyzine, macrolides, ondansetron, etc.) or drugs containing any of the following: flecainide, metoprolol, imipramine, amitriptyline, clomipramine
  • Known allergic reactions to DP or other artemisinin derivatives
  • Pregnancy

研究组 & 干预措施

Intervention with 2 TDA rounds

Active Comparator

TDA with DP will be administered two times with a 4 - 6 week interval between rounds to all workers in the selected farm sites

干预措施: Dihydroartemisinin-piperaquine (Drug)

Intervention with 3 TDA rounds

Active Comparator

TDA with DP will be administered three times with a 4 - 6 week interval between rounds to all workers in the selected farm sites

干预措施: Dihydroartemisinin-piperaquine (Drug)

结局指标

主要结局

Feasibility of TDA

时间窗: Up to 6 months

Feasibility of TDA measured through intervention coverage (% of participants treated among the total farm population) and cost effectiveness

Plasmodium falciparum (Pf) parasite prevalence

时间窗: Up to 6 months

Prevalence of Pf as determined by PCR at the end of the study

Acceptability of TDA amongst farmworkers, farm-site owners, and local health authorities

时间窗: Up to 6 months

Acceptability of TDA amongst farmworkers, farm-site owners, and local health authorities measured through drug adherence (% of participants completing the drugs as prescribed, as reported in the endline survey), survey response (self-reported values provided during endline survey), and qualitative interview data

次要结局

  • Feasibility and acceptability of enhanced case management through mobile clinics based on endline survey responses(Up to 6 months)
  • Feasibility of enhanced case management through mobile clinics based on cost per case detected(Up to 6 months)
  • Feasibility and acceptability of enhanced case management through mobile clinics based on qualitative interview data(Up to 6 months)
  • Pf parasite prevalence in a subset of migrant farmworkers(Up to 2 months)
  • Safety and tolerability of TDA(Up to 6 months)

研究者

发起方
PATH
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验